You are here

  • Home
  • Archive
  • Volume 102, Issue Suppl 6
  • 109 Marked Differences in the Pharmacodynamics of Modern P2Y12 Inhibitors in Patients Undergoing Treatment for ST Segment Elevation MI (STEMI) and Non ST Segment Elevation MI (NSTEMI)

Citation Tools

Article menu

Download PDFPDF

Heart View
Acute Coronary Syndromes
109 Marked Differences in the Pharmacodynamics of Modern P2Y12 Inhibitors in Patients Undergoing Treatment for ST Segment Elevation MI (STEMI) and Non ST Segment Elevation MI (NSTEMI)
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Amoah V, Khan N, Smallwood A, et al
109 Marked Differences in the Pharmacodynamics of Modern P2Y12 Inhibitors in Patients Undergoing Treatment for ST Segment Elevation MI (STEMI) and Non ST Segment Elevation MI (NSTEMI)
Heart 2016;102:A77-A78.